Frequency News and Research

RSS

Focused Ultrasound Surgery Foundation disbursed $1 million in research awards; looks forward to fund more projects in 2010

The Focused Ultrasound Surgery Foundation has disbursed nearly $1 million in research awards for work on a breakthrough medical technology and is making more project funding available in 2010.

22 Jan 2010

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

Ordinary face masks and hand hygiene can effectively reduce the transmission of influenza-like illness during flu season. The finding comes from a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650396), published in the Feb. 15 issue of the Journal of Infectious Diseases.

22 Jan 2010

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.

21 Jan 2010

Elevation Pharmaceuticals closes $30M tranched Series A financing

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing.

21 Jan 2010

Engaging in incentive-based wellness program is associated with lower healthcare costs

According to a study published in the January/February issue of the American Journal of Health Promotion, a peer-reviewed journal devoted to health promotion, health plan members who participated in fitness-related activities within an incentive-based health insurance wellness program had significantly lower healthcare costs.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

Impact of life style factors on natural and medically assisted reproduction

The European Society of Human Reproduction and Embryology (ESHRE) has published a position statement on the impact of the life style factors obesity, smoking and alcohol consumption on natural and medically assisted reproduction.

20 Jan 2010

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

An online treatment system for patients suffering with panic disorder and anxiety problems combine biofeedback therapy with web technologies and allows patients and medical professionals to communicate effectively, according to research published in the International Journal of Business Intelligence and Data Mining.

20 Jan 2010

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

U-Systems announced today that Radiology Regional Center has initiated participation in the SOMO•INSIGHT Clinical Study. The first breast center in Southwest Florida to participate, Radiology Regional Center is recruiting participants for the national clinical research study designed to evaluate whether digital mammography in combination with the somo•v™ Automated Breast Ultrasound System (ABUS) from U-Systems is more sensitive to detecting breast lesions when compared to Mammography alone in women with dense breasts.

20 Jan 2010

Effects of obesity, smoking and drinking on natural and medically assisted reproduction

19 Jan 2010

Voice abnormalities in cochlear implants will improve over time, says study

Children with cochlear implants in both ears appear to have difficulty controlling the loudness and pitch of their voices, but these measures improve over time, according to a report in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

19 Jan 2010

Unique partnership leverages funds and technology to track and improve breast screening program

The Canadian Breast Cancer Foundation - Atlantic announced today a first-of-its-kind partnership between the breast screening programs of Nova Scotia and Newfoundland and Labrador that yield benefits that could extend to the rest of Canada and beyond.

19 Jan 2010

Hyperphosphatemia following standard OSP doses is related to weight, reveals study

Colon cleansing is used widely for colonoscopic exploration and colonic and gynecological surgery. Oral sodium phosphate (OSP) solution is the osmotic laxative most commonly used for this purpose. It is known that OSP can induce severe hyperphosphatemia and hypocalcemia due to excessive absorption of phosphates, and there have been reports of deaths and irreversible dialysis-requiring renal insufficiency. However, no prospective studies have investigated the prevalence of hyperphosphatemia in low-risk patients.

18 Jan 2010

Role of H. pylori in autoimmune atrophic gastritis

Experimental animal studies have shown that H. pylori shares several antigenic regions in common with acid secreting cells in gastric mucosa. Antibodies triggered by H. pylori destroy acid secreting cells due to this antigenic mimicry.

17 Jan 2010

Scientists identify fast-acting compound to improve cognitive function impairments

A fast-acting compound that appears to improve cognitive function impairments in mice similar to those found in patients with progressive Alzheimer's disease has been identified by scientists at Wake Forest University School of Medicine and the Vanderbilt University Medical Center Program in Drug Discovery.

13 Jan 2010

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

11 Jan 2010

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

SRI International Dedicates New Tampa Bay Research Facility SRI International, one of the world's leading independent research and technology development organizations, officially opened its new 40,000-square-foot research facility located at the Port of St. Petersburg.

11 Jan 2010

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Vertex Pharmaceuticals Incorporated today provided an update on key 2010 business priorities in conjunction with the 28th Annual J.P. Morgan Healthcare Conference in San Francisco. The company also discussed recent progress in its lead development programs in hepatitis C virus (HCV) infection and cystic fibrosis (CF) and outlined proof-of-concept clinical trials planned in other serious diseases for 2010.

11 Jan 2010

Clinical Foundations' edition provides comprehensive review of hospital-acquired infections

Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled “Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist.”

9 Jan 2010

Immune cells causes inflammation in thyroid-associated ophthalmopathy

A cell type that causes significant scarring in lung disease appears to have a similar effect in Graves' disease, University of Michigan Health System researchers have found. The cells, called fibrocytes, are present at a higher than normal frequency in patients with Graves' disease, according to a new study, the first to associate fibrocytes with this autoimmune disease.

9 Jan 2010

Frequency News and Research

Focused Ultrasound Surgery Foundation disbursed $1 million in research awards; looks forward to fund more projects in 2010

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

Elevation Pharmaceuticals closes $30M tranched Series A financing

Engaging in incentive-based wellness program is associated with lower healthcare costs

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Impact of life style factors on natural and medically assisted reproduction

Intelligent panic disorder treatment by using biofeedback analysis and web technologies

Radiology Regional Center initiates participation in SOMO•INSIGHT Clinical Study

Effects of obesity, smoking and drinking on natural and medically assisted reproduction

Voice abnormalities in cochlear implants will improve over time, says study

Unique partnership leverages funds and technology to track and improve breast screening program

Hyperphosphatemia following standard OSP doses is related to weight, reveals study

Role of H. pylori in autoimmune atrophic gastritis

Scientists identify fast-acting compound to improve cognitive function impairments

Results from Phase 2a clinical trial of Raptor Pharmaceutical's cysteamine bitartrate published

Tampa Bay Partnership releases new briefs on the economic and business growth in the Tampa Bay Region

Vertex Pharmaceuticals plans proof-of-concept clinical trials in RA and epilepsy

Clinical Foundations' edition provides comprehensive review of hospital-acquired infections

Immune cells causes inflammation in thyroid-associated ophthalmopathy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News